Several compounds to improve cognition in schizophrenia are being studied in clinical trials, but little is known about how clinicians conceptualize the cognitive deficits of schizo-phrenia. In a pilot study, the author asked 40 psychiatrists 3 brief questions about the clinical presentation of cognitive deficits. Descriptions of cognitive deficits show high variabil-ity. Informants describe phenomenology like follow-through, attention,andemptinessasindicativeofcognitiveimpairment. Informants ’ concepts of cognitive deficits overlap substan-tially with positive, negative, and thought disorder symptoms. Clinicians ’ concepts are complex and contextualized, in contrast to the discrete skills measured by neuropsychol-ogical tests. Results sugg...
In light of the number of studies conducted to examine the treatment of cognitive impairment associa...
Neurocognitive impairment is considered a core component of schizophrenia and is increasingly under ...
The search is on for meaningful psychopharmacologi-cal and cognitive/behavioral interventions for ne...
INTRODUCTION: Schizophrenia is a severe mental disorder with multiple psychopathological domains bei...
Introduction: Schizophrenia is a severe mental disorder with multiple psychopathological domains bei...
Schizophrenia is a disabling, chronic psychiatric disorder with a prevalence rate of 0.5-1% in the g...
Schizophrenia is a major mental illness characterized by positive and negative symptoms, and by cogn...
Introduction - Schizophrenia is a severe mental disorder with multiple psychopathological domains be...
Neuropsychiatric diseases, such as schizophrenia, Alzheimer's disease, and etc., represent a serious...
BACKGROUND: Schizophrenia is a disorder characterized by pervasive deficits in cognitive functioning...
Application of a neuropsychological perspective to the study of schizophrenia has established a numb...
Application of a neuropsychological perspective to the study of schizophrenia has established a numb...
INTRODUCTION: Cognitive impairment is a pervasive feature of schizophrenia, and is a major determina...
In light of the number of studies conducted to examine the treatment of cognitive impairment associa...
# Springer-Verlag 2008Introduction Schizophrenia is often associated with chronic disability and poo...
In light of the number of studies conducted to examine the treatment of cognitive impairment associa...
Neurocognitive impairment is considered a core component of schizophrenia and is increasingly under ...
The search is on for meaningful psychopharmacologi-cal and cognitive/behavioral interventions for ne...
INTRODUCTION: Schizophrenia is a severe mental disorder with multiple psychopathological domains bei...
Introduction: Schizophrenia is a severe mental disorder with multiple psychopathological domains bei...
Schizophrenia is a disabling, chronic psychiatric disorder with a prevalence rate of 0.5-1% in the g...
Schizophrenia is a major mental illness characterized by positive and negative symptoms, and by cogn...
Introduction - Schizophrenia is a severe mental disorder with multiple psychopathological domains be...
Neuropsychiatric diseases, such as schizophrenia, Alzheimer's disease, and etc., represent a serious...
BACKGROUND: Schizophrenia is a disorder characterized by pervasive deficits in cognitive functioning...
Application of a neuropsychological perspective to the study of schizophrenia has established a numb...
Application of a neuropsychological perspective to the study of schizophrenia has established a numb...
INTRODUCTION: Cognitive impairment is a pervasive feature of schizophrenia, and is a major determina...
In light of the number of studies conducted to examine the treatment of cognitive impairment associa...
# Springer-Verlag 2008Introduction Schizophrenia is often associated with chronic disability and poo...
In light of the number of studies conducted to examine the treatment of cognitive impairment associa...
Neurocognitive impairment is considered a core component of schizophrenia and is increasingly under ...
The search is on for meaningful psychopharmacologi-cal and cognitive/behavioral interventions for ne...